Investor
LSX Nordic Congress
An investment and partnering conference linking life science executives in the Nordic region with international pharmaceutical partners and global healthcare investors.
- When
- September, Early September
- Where
- RotatingView on Google Maps
- Format
- In person
- Organiser
- LSX Ltd
- Region
- Europe
- Scale
- About 600 attendees
- Founded
- 2018
The Signal
The LSX Nordic Congress is an annual partnering and investment meeting focused on the biotechnology, medtech, and digital health sectors in Northern Europe. Organized by LSX, it prioritizes structured business matchmaking alongside panel sessions on international scaling, funding, and corporate development. It serves to connect regional life science startups with global pharmaceutical executives and international venture capital firms. For healthcare operators, it offers concentrated access to specialized capital and potential corporate acquirers.
What to expect
- Nordic life science investment and fundraising trends
- Cross-border pharmaceutical licensing partnerships
- Strategic growth challenges for European biotechs
Who is in the room
Attendees are biotechnology executives, medical technology founders, international life science venture capitalists, and pharmaceutical business development directors.
Background
Launched as part of the LSX conference series, the Nordic edition was established to address the region's strong life science research base. It has become the primary autumn meeting for Nordic biotech and medtech investment.
Related events
Running this event, or spotted something out of date?